Complications of intravenous immune globulin treatment in neurologic disease.
about
Intravenous Immunoglobulins as a Treatment for Alzheimerʼs DiseaseIntravenous immunoglobulins for multiple sclerosisA case of deep vein thrombosis and pulmonary thromboembolism after intravenous immunoglobulin therapyChronic inflammatory demyelinating polyneuropathies: current treatment strategiesTransverse sinus thrombosis and IVIg treatment: a case report and discussion of risk-benefit assessment for immunoglobulin treatmentWill it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?Thromboembolic events as an emerging adverse effect during high-dose intravenous immunoglobulin therapy in elderly patients: a case report and discussion of the relevant literature.Cerebral venous thrombosis after immune thrombocytopenic purpura and anti-D immune globulin therapy.Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines.Facial vasculitic rash associated with intravenous immunoglobulin.Intravenous immunoglobulin in neurological disease: a specialist review.Thrombosis complicating high dose intravenous immunoglobulin: report of three cases and review of the literature.IVIG in autoimmunity and cancer--efficacy versus safety.Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTs.Multifocal motor neuropathy: current concepts and controversies.Review: intravenous immunoglobulin therapy and thromboembolic complications.Myasthenia gravis: a review.Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancyIntravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.Adverse effects of treatment with intravenous immunoglobulins for neurological diseases.Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityCurrent treatments of chronic immune-mediated demyelinating polyneuropathies.Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.Recent approaches to the development of antigen-specific immunotherapies for myasthenia gravis.Special considerations with the use of intravenous immunoglobulin in older persons.Evidence-based strategies to reduce intravenous immunoglobulin-induced headaches.Early platelet and leukocyte decline in patients with neuroinflammatory disorders after intravenous immunoglobulins.Thromboembolic complications of intravenous immunoglobulin (IVIG) in an immunocompromised patient with Chronic Lymphocytic Leukemia: a case report.In vitro cytotoxic effects of stabilizing sugars within human intravenous immunoglobulin preparations against the human macrophage THP-1 cell-line.Safety of intravenous immunoglobulin in the elderly treated for a dysimmune neuromuscular disease.Intravenous immunoglobulin as therapy for pediatric Guillain-Barré syndrome.Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin.Case-control study of thromboembolic events associated with IV immunoglobulin.Long-term treatment of myasthenia gravis with immunoadsorption.Cost-utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy.How effective is intravenous immunoglobulin for the treatment of relapsing-remitting multiple sclerosis?Side effects of combined therapy of methylprednisolone and intravenous immunoglobulin in Guillain-Barré syndrome.A treatment algorithm for autoimmune myasthenia gravis in childhood.
P2860
Q22241424-FF264C48-30ED-4514-B560-D3053441C527Q24247968-E0DA9323-CF1C-48B6-9B6D-DBDB27DA07C3Q28220499-FF91167B-BFFA-4429-A24C-932F89941344Q28282910-69459E2E-68A2-4563-A4AE-B0F64E555990Q33347181-C0E21D6B-0FF3-413C-94F4-711C9381CA2BQ33348098-ADD6B1C7-892D-485B-BED2-AE2702BAC604Q33362140-5F408AFB-EABD-4F9D-9D5F-96630E38F0C7Q33378213-3D35AD03-E432-4C9F-BAC0-7DC5764476E5Q33748109-2BA4DECA-922C-4EE7-AE75-4B16CED83E75Q33853749-16FF0F7F-0D4E-49F7-BFC7-044F4D5C9262Q34574581-7284BD15-68C8-4CDC-A631-3B413AEDB547Q35161305-99260F40-A216-493F-A682-6E59FD7BC8F2Q35194511-91426B13-F3BB-48F5-A5CB-5B0CBA8378C4Q35955607-72923C9A-5CD9-48ED-BEA0-4CE28EEBE389Q36072147-539EC2B0-F81B-426B-A0DB-DB282F59299AQ36319341-262FB3A8-6A02-4719-AD21-16AA8376A7B1Q36410472-339B5E20-2C76-4B55-ADF3-2289B2E6F5CDQ36463391-34E1B613-D20B-4FA8-8975-4C6107967645Q36590745-FB6525FE-9A97-4158-8889-CD25C2B55403Q36602804-E00CC443-C631-4AE2-8A23-91D4A6A5F5B1Q36794149-CAB7CE80-2827-46A1-B32D-823325361E79Q36807468-0EB4CC73-EDC1-41C0-81E6-A0909ABA666DQ37315963-7840A74B-DB39-444F-A25D-B03166AE9AF4Q37419250-56CCB4B5-3033-44ED-8501-F7BD354A0369Q37600787-20BFFBB0-C984-4297-99DB-74C09B0B3EDCQ37699350-DC537CAF-B07A-4920-B502-7836D1F20AB9Q37931231-4D864E79-D7B6-4598-B903-7339CB207AB3Q38372260-64016919-B045-434D-B851-8B9D8D4FC7C5Q38948629-DFAFBD3C-721E-4316-817D-103E7003BDDCQ40369173-4076501F-A247-4C27-920A-103219A7E03BQ40628679-EB388FBC-6BCB-4954-8646-A2192BD03AE0Q41221031-4DFC2696-20AF-47CB-AE43-A9862C66CDC7Q41601346-EC65992E-B122-4E51-8B15-74C5EA7B7D68Q42595540-7BF2749B-4E1E-4E4C-943D-5C1FF7C2FF95Q43422324-69EE61C4-1F19-47D7-99C7-1CF840CD908BQ44124870-847EEAD2-362D-47A5-8E50-2D3DCB3EB085Q44670941-506B2557-658D-4665-9B84-346020FDEDFBQ46318463-D445DD58-6A28-46D6-B652-16670BE92240Q46560452-D2F6BCC3-E706-4EDF-9891-16743C6A0A7DQ47826083-A8D38084-22B0-46A2-A04D-79AC07905D82
P2860
Complications of intravenous immune globulin treatment in neurologic disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Complications of intravenous immune globulin treatment in neurologic disease.
@en
type
label
Complications of intravenous immune globulin treatment in neurologic disease.
@en
prefLabel
Complications of intravenous immune globulin treatment in neurologic disease.
@en
P2093
P356
P1433
P1476
Complications of intravenous immune globulin treatment in neurologic disease.
@en
P2093
Brannagan TH 3rd
Rowland LP
P304
P356
10.1212/WNL.47.3.674
P407
P577
1996-09-01T00:00:00Z